Fusion Antibodies Dividend
Dividend criteria checks 0/6
Fusion Antibodies does not have a record of paying a dividend.
Key information
n/a
Dividend yield
n/a
Payout ratio
Industry average yield | 0.6% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | -UK£0.03 |
Dividend yield forecast in 3Y | n/a |
Recent dividend updates
No updates
Recent updates
Here's Why We're Not At All Concerned With Fusion Antibodies' (LON:FAB) Cash Burn Situation
Aug 31Here's Why We're Not Too Worried About Fusion Antibodies' (LON:FAB) Cash Burn Situation
Jan 25We Think Fusion Antibodies (LON:FAB) Can Easily Afford To Drive Business Growth
May 09Investors Who Bought Fusion Antibodies (LON:FAB) Shares A Year Ago Are Now Up 146%
Mar 17Companies Like Fusion Antibodies (LON:FAB) Can Afford To Invest In Growth
Jan 04Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if FAB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if FAB's dividend payments have been increasing.
Dividend Yield vs Market
Fusion Antibodies Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (FAB) | n/a |
Market Bottom 25% (GB) | 2.2% |
Market Top 25% (GB) | 5.9% |
Industry Average (Life Sciences) | 0.6% |
Analyst forecast in 3 Years (FAB) | n/a |
Notable Dividend: Unable to evaluate FAB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate FAB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate FAB's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as FAB has not reported any payouts.